Long term weight loss is a desired goal for obese individuals. Individuals with a BMI (Body Mass Index) score of over 40 are considered morbidly obese. Obesity causes diseases such as diabetes, cancer, hypertension, high cholesterol, coronary artery disease, sleep apnea, liver and pulmonary disease, and others. It can also lead to anxiety, depression, substance abuse, chronic pain, insomnia, social isolation and sexual dysfunction.

Morbid obesity for example, can be effectively treated with laparoscopic surgery such as the lap band. Then the weight loss can be maintained with the help of medications such as the upcoming Contrave (developed by Orexigen Therapuetics, Inc). Contrave contains two appetite suppressants: naltrexone HCL and bupropion HCL.

When an individual is going through initial weight loss, the brain is conditioned to trigger hunger in the body and to slow down the metabolism. These hunger signals are counter-productive to weight loss, and excess weight could return as one relents to the demands of the brain. In order to maintain long term weight loss, one option is to use Contrave. Its active ingredient bupropion HCL initiates the weight loss, and its naltrexone maintains the weight loss. Bupropion is a widely-prescribed antidepressant and smoking cessation medication; naltrexone is a treatment for alcohol addiction. The two ingredients work to inhibit the neural circuits in the brain that cause hunger.

Dr. David Davtyan, an expert in laparoscopic surgery, has extensive experience helping patients achieve long term weight loss.

Call 1-877-9BESLIM (923-7546) for more information today!

More resources about Contrave:

Rupert Shepherd B.Sc. Promising New Obesity Drug Contrave® Looks Set For FDA Approval.”

Medical News Today. MediLexicon, Intl., 22 Sep. 2011. Web.

24 Oct. 2011.